Gregory D. Aunan's most recent trade in Neogenomics Inc. was a trade of 5,372 Common Stock done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 5,372 | 18,888 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2025 | 1,309 | 17,579 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2025 | 937 | 13,516 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 31,163 | 31,163 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 18,971 | 18,971 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 26,978 | 26,978 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 16,117 | 16,117 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Gregory D. Aunan | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2024 | 937 | 14,453 (0%) | 0% | 0 | Common Stock |